A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia (clinicaltrials.gov) - Sep 11, 2026 - P2 | N=189 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting
Enrollment closed • Anemia • Genetic Disorders • Hematological Disorders
|